Insider: Young Jonathan Chief Operating Officer - Akero Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 196,898 | 0 | 196,898 |
| Value | $9,252,237.02 | $0.00 | $9,252,237.02 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 09/11/2025 | DDS | 586 | Direct | COM | $43.02 | $25,209.72 | 196,898 |
| 09/02/2025 | DDS | 9,700 | Direct | COM | $45.78 | $444,027.20 | 200,284 |
| 09/02/2025 | DDS | 61 | Direct | COM | $47.58 | $2,902.38 | 197,484 |
| 09/02/2025 | DDS | 2,739 | Direct | COM | $47.14 | $129,105.50 | 197,545 |
| 08/12/2025 | DDS | 11,151 | Direct | COM | $47.72 | $532,136.87 | 198,833 |
| 08/12/2025 | DDS | 1,349 | Direct | COM | $48.32 | $65,189.08 | 197,484 |
| 06/18/2025 | DDS | 1,453 | Direct | COM | $54.84 | $79,682.52 | 196,594 |
| 06/10/2025 | DDS | 2,493 | Direct | COM | $53.99 | $134,604.55 | 198,047 |
| 03/12/2025 | DDS | 607 | Direct | COM | $44.88 | $27,242.16 | 200,540 |
| 03/04/2025 | DDS | 11,447 | Direct | COM | $44.17 | $505,591.10 | 239,700 |
| 03/04/2025 | DDS | 38,553 | Direct | COM | $45.07 | $1,737,622.26 | 201,147 |
| 02/03/2025 | DDS | 5,100 | Direct | COM | $53.57 | $273,181.50 | 256,047 |
| 02/03/2025 | DDS | 4,900 | Direct | COM | $54.06 | $264,879.30 | 251,147 |
| 01/02/2025 | DDS | 10,000 | Direct | COM | $28.03 | $280,330.00 | 218,083 |
| 12/10/2024 | DDS | 2,503 | Direct | COM | $30.79 | $77,067.37 | 203,783 |
| 12/02/2024 | DDS | 10,000 | Direct | COM | $32.13 | $321,310.00 | 206,286 |
| 11/01/2024 | DDS | 15,481 | Direct | COM | $32.27 | $499,525.43 | 216,578 |
| 11/01/2024 | DDS | 34,943 | Direct | COM | $31.25 | $1,092,108.52 | 232,059 |
| 11/01/2024 | DDS | 292 | Direct | COM | $32.94 | $9,617.60 | 216,286 |
| 10/14/2024 | DDS | 40,000 | Direct | COM | $30.15 | $1,206,080.00 | 226,286 |
| 10/01/2024 | DDS | 10,000 | Direct | COM | $28.18 | $281,770.00 | 226,286 |
| 09/10/2024 | DDS | 568 | Direct | COM | $26.18 | $14,870.24 | 236,286 |
| 09/03/2024 | DDS | 1,290 | Direct | COM | $27.58 | $35,573.04 | 236,854 |
| 09/03/2024 | DDS | 3,710 | Direct | COM | $26.42 | $98,014.49 | 238,144 |
| 08/01/2024 | DDS | 3,031 | Direct | COM | $26.44 | $80,139.64 | 243,823 |
| 1 2 3 Next Last You are at page 1 of 3 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research